FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to a new agent for stimulating angiogenesis in a subject, and can be used in medicine. The invention can be used in medical practice as an agent that stimulates angiogenesis and promotes wound healing in a subject.
EFFECT: invention makes it possible to obtain a chemical compound representing a tetrameric form of the His-His-His-Arg-His-Ser-Phe peptide linearly linked to PEG fragments to form the said multimeric form.
41 cl, 8 dwg, 20 ex
| Title |
Year |
Author |
Number |
| HUMAN PROTEIN TYROSINE PHOSPHATASE BETA BINDING ANTIBODIES (HPTPBETA), AND USE THEREOF |
2007 |
- Rotello Rocco Jamie
- Peters Kevin Gene
- Davis Michael Glen
|
RU2494108C2 |
| COMBINATIONS AND COMPOSITIONS EFFECTING ON FUNCTION OF VEGF/VEGF RECEPTOR AND ANGIOPOIETIN/TIE(II) RECEPTOR SYSTEMS AND USES THEREOF |
2001 |
- Zimajster Gerkhard
- Khaberehj Martin
- Tiraukh Karl-Khajnts
|
RU2292221C2 |
| BISPECIFIC BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES |
2011 |
- Bener Monika
- Imkhof-Yung Zabine
- Kavle Anita
- Kettenberger Gubert
- Klyajn Kristian
- Regula Jorg Tomas
- Shefer Volfgang
- Shantser Jyurgen Mikhel
- Shojer Verner
- Shtubenraukh Kaj-Gunnar
- Tomas Markus
|
RU2597973C2 |
| METHOD FOR REDUCING MULTI-DRUG RESISTANCE WITH USING INOSITOL TRIPYROPHOSPHATE |
2010 |
- Nikolau Iv Klod
- Len Zhan-Mari
- Kieda Klodin
|
RU2563127C2 |
| NUCLEIC ACID MOLECULE ENCODING LIGAND TIE-2, LIGAND TIE-2 AND METHOD FOR ITS PREPARING, VECTOR, STRAIN OF CELLS COS, ANTIBODY, CONJUGATE OF LIGAND TIE-2, LIGAND BODY, PHARMACEUTICAL COMPOSITION, METHOD FOR PROPHYLAXIS OR ATTENUATION OF NEOVASCULARIZATION AND METHOD FOR IDENTIFICATION OF TIE-2 RECEPTOR ANTAGONIST |
1995 |
- Dehvis Sehmjuehl'
- Bruno Dzhoan
- Goldfarb Mitchell
- Oldrich Tomas Kh.
- Mehjsonp'Er Piter S.
- Radzievski Cheslav
- Dzhons Pamela F.
- Jankopulos Dzhordzh D.
|
RU2233330C2 |
| INTEGRIN-TARGETING PROTEIN AND THE METHODS OF ITS USE |
2016 |
- Yang, Jenny
- Turaga, Chakra, Ravi
- Liu, Zhi-Ren
|
RU2806524C2 |
| ISOLATED TIE-LIGAND-4 AND ITS ISOLATED FIBRINOGEN-LIKE DOMAIN; ISOLATED NUCLEIC ACID MOLECULE ENCODING INDICATED LIGAND; VECTOR COMPRISING INDICATED NUCLEIC ACID; METHOD FOR PREPARING HOST-CELL TRANSFORMED WITH INDICATED VECTOR; METHOD FOR PREPARING TIE-LIGAND-4; CONJUGATE COMPRISING INDICATED LIGAND; LIGAND-BODY COMPRISING INDICATED FIBRINOGEN-LIKE DOMAIN |
1997 |
- Valenzuela Dehvid M.
- Dzhounz Pamela F.
- Jankopoulos Dzhordzh D.
|
RU2242514C2 |
| MAST CELL STABILIZERS FOR THE TREATMENT OF HYPERCYTOKINEMIA AND VIRAL INFECTION |
2017 |
- Hyde-Deruyscher, Robin Parish
- Hyde-Deruyscher, Nancy Harlan
- Hyde-Deruyscher, Elicia Kristine
|
RU2760682C2 |
| COMPOSITIONS AND METHODS FOR PROTECTION FROM AIR-SUSPENDED PATHOGENS AND IRRITANTS |
2018 |
|
RU2790223C2 |
| ISOLATED NUCLEIC ACID MOLECULE ENCODING LIGAND TIE-2, LIGAND TIE-2 AND METHOD FOR PREPARING, PLASMID (VARIANTS), ANTIBODY, CONJUGATE, LIGAND BODY, PHARMACEUTICAL COMPOSITION, METHOD FOR STIMULATING NEO-VASCULARIZATION, METHOD FOR CELL MAINTENANCE, METHOD FOR IDENTIFYING TIE-2 RECEPTOR ANTAGONIST |
1995 |
- Dehvis Sehmjuehl'
- Bruno Dzhoan
- Goldfarb Mitchell
- Oldrich Tomas Kh.
- Mehjsonp'Er Piter S.
- Radzievski Cheslav
- Dzhons Pamela F.
- Jankopulos Dzhordzh D.
|
RU2232812C2 |
